0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and India Therapeutic Enzymes Market Report & Forecast 2023-2029
Published Date: November 2023
|
Report Code: QYRE-Auto-23N15618
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global and India Therapeutic Enzymes Market Report Forecast 2023 2029
BUY CHAPTERS

Global and India Therapeutic Enzymes Market Report & Forecast 2023-2029

Code: QYRE-Auto-23N15618
Report
November 2023
Pages:104
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

and India Therapeutic Enzymes Market Size

The global Therapeutic Enzymes revenue was US$ 7485.2 million in 2022 and is forecast to a readjusted size of US$ 16800 million by 2029 with a CAGR of 12.1% during the forecast period (2023-2029).

and India Therapeutic Enzymes Market

and India Therapeutic Enzymes Market

Therapeutic enzymes have a broad variety of specific uses, Oncolytics, Anticoagulants, Thrombolytics, Replacements for metabolic deficiencies, Digestive aids, Metabolic storage disorders, etc. Miscellaneous enzymes of diverse function.
In India, the Therapeutic Enzymes revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2023-2029).
Sanofi was the global greatest company in Therapeutic Enzymes industry, with the revenue market Share of 33% , followed by BioMarin, AbbVie , Shire, Alexion, Horizon Pharma, Allergan, Johnson & Johnson, Recordati Rare Diseases, Pfizer, Vivus, Digestive Care, Leadiant Biosciences.North America is the largest Therapeutic Enzymes market with about 70% market share. Europe is follower, accounting for about 21% market share.
This report focuses on global and India Therapeutic Enzymes market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Therapeutic Enzymes will continue to grow rapidly in the future.
Global Therapeutic Enzymes Scope and Market Size
Therapeutic Enzymes market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Therapeutic Enzymes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2029.
For India market, this report focuses on the Therapeutic Enzymes market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India Therapeutic Enzymes Market Report

Report Metric Details
Report Name and India Therapeutic Enzymes Market
Forecasted market size in 2029 US$ 16800 million
CAGR 12.1%
Forecasted years 2023 - 2029
Segment by Type
  • Injectable
  • Oral
  • Topical
Segment by Application
  • Gaucher Disease
  • MPS Disease
  • Gastrointestinal Diseases
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Sanofi, BioMarin, AbbVie, Shire, Alexion, Horizon Pharma, Allergan, Johnson & Johnson, Recordati Rare Diseases, Pfizer, Vivus, Digestive Care, Leadiant Biosciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India Therapeutic Enzymes Market size in 2029?

Ans: The and India Therapeutic Enzymes Market size in 2029 will be US$ 16800 million.

What is the Sanofi, BioMarin, AbbVie, Shire, Alexion, Horizon Pharma, Allergan, Johnson & Johnson, Recordati Rare Diseases, Pfizer, Vivus, Digestive Care, Leadiant Biosciences share in and India Therapeutic Enzymes Market?

Ans: Sanofi was the global greatest company in Therapeutic Enzymes industry, with the revenue market Share of 33% , followed by BioMarin, AbbVie , Shire, Alexion, Horizon Pharma, Allergan, Johnson & Johnson, Recordati Rare Diseases, Pfizer, Vivus, Digestive Care, Leadiant Biosciences.

What is the and India Therapeutic Enzymes Market share by region?

Ans: Europe is follower, accounting for about 21% market share. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

Who are the main players in the and India Therapeutic Enzymes Market report?

Ans: The main players in the and India Therapeutic Enzymes Market are Sanofi, BioMarin, AbbVie, Shire, Alexion, Horizon Pharma, Allergan, Johnson & Johnson, Recordati Rare Diseases, Pfizer, Vivus, Digestive Care, Leadiant Biosciences

What are the Application segmentation covered in the and India Therapeutic Enzymes Market report?

Ans: The Applications covered in the and India Therapeutic Enzymes Market report are Gaucher Disease, MPS Disease, Gastrointestinal Diseases, Others

What are the Type segmentation covered in the and India Therapeutic Enzymes Market report?

Ans: The Types covered in the and India Therapeutic Enzymes Market report are Injectable, Oral, Topical

1 Study Coverage
1.1 Therapeutic Enzymes Product Introduction
1.2 Global Therapeutic Enzymes Outlook 2018 VS 2022 VS 2029
1.2.1 Global Therapeutic Enzymes Sales in US$ Million for the Year 2018-2029
1.2.2 Global Therapeutic Enzymes Sales in Volume for the Year 2018-2029
1.3 India Therapeutic Enzymes Outlook 2018 VS 2022 VS 2029
1.3.1 India Therapeutic Enzymes Sales in US$ Million for the Year 2018-2029
1.3.2 India Therapeutic Enzymes Sales in Volume for the Year 2018-2029
1.4 Therapeutic Enzymes Market Size, India VS Global, 2018 VS 2022 VS 2029
1.4.1 The Market Share of India Therapeutic Enzymes in Global, 2018 VS 2022 VS 2029
1.4.2 The Growth Rate of Therapeutic Enzymes Market Size, India VS Global, 2018 VS 2022 VS 2029
1.5 Therapeutic Enzymes Market Dynamics
1.5.1 Therapeutic Enzymes Industry Trends
1.5.2 Therapeutic Enzymes Market Drivers
1.5.3 Therapeutic Enzymes Market Challenges
1.5.4 Therapeutic Enzymes Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Therapeutic Enzymes by Type
2.1 Therapeutic Enzymes Market Segment by Type
2.1.1 Injectable
2.1.2 Oral
2.1.3 Topical
2.2 Global Therapeutic Enzymes Market Size by Type
2.2.1 Global Therapeutic Enzymes Sales in Value, by Type (2018, 2022 & 2029)
2.2.2 Global Therapeutic Enzymes Sales in Volume, by Type (2018, 2022 & 2029)
2.2.3 Global Therapeutic Enzymes Average Selling Price (ASP) by Type (2018, 2022 & 2029)
2.3 India Therapeutic Enzymes Market Size by Type
2.3.1 India Therapeutic Enzymes Sales in Value, by Type (2018, 2022 & 2029)
2.3.2 India Therapeutic Enzymes Sales in Volume, by Type (2018, 2022 & 2029)
2.3.3 India Therapeutic Enzymes Average Selling Price (ASP) by Type (2018, 2022 & 2029)
3 Therapeutic Enzymes by Application
3.1 Therapeutic Enzymes Market Segment by Application
3.1.1 Gaucher Disease
3.1.2 MPS Disease
3.1.3 Gastrointestinal Diseases
3.1.4 Others
3.2 Global Therapeutic Enzymes Market Size by Application
3.2.1 Global Therapeutic Enzymes Sales in Value, by Application (2018, 2022 & 2029)
3.2.2 Global Therapeutic Enzymes Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 Global Therapeutic Enzymes Average Selling Price (ASP) by Application (2018, 2022 & 2029)
3.3 India Therapeutic Enzymes Market Size by Application
3.3.1 India Therapeutic Enzymes Sales in Value, by Application (2018, 2022 & 2029)
3.3.2 India Therapeutic Enzymes Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 India Therapeutic Enzymes Average Selling Price (ASP) by Application (2018, 2022 & 2029)
4 Global Therapeutic Enzymes Competitor Landscape by Company
4.1 Global Therapeutic Enzymes Market Size by Company
4.1.1 Global Key Manufacturers of Therapeutic Enzymes, Ranked by Revenue (2022)
4.1.2 Global Therapeutic Enzymes Revenue by Manufacturer (2018-2023)
4.1.3 Global Therapeutic Enzymes Sales by Manufacturer (2018-2023)
4.1.4 Global Therapeutic Enzymes Price by Manufacturer (2018-2023)
4.2 Global Therapeutic Enzymes Concentration Ratio (CR)
4.2.1 Therapeutic Enzymes Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Therapeutic Enzymes in 2022
4.2.3 Global Therapeutic Enzymes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Therapeutic Enzymes, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Therapeutic Enzymes, Product Offered and Application
4.5 Global Key Manufacturers of Therapeutic Enzymes, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 India Therapeutic Enzymes Market Size by Company
4.7.1 Key Players of Therapeutic Enzymes in India, Ranked by Revenue (2022)
4.7.2 India Therapeutic Enzymes Revenue by Players (2018-2023)
4.7.3 India Therapeutic Enzymes Sales by Players (2018-2023)
5 Global Therapeutic Enzymes Market Size by Region
5.1 Global Therapeutic Enzymes Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Therapeutic Enzymes Market Size in Volume by Region (2018-2029)
5.2.1 Global Therapeutic Enzymes Sales in Volume by Region: 2018-2023
5.2.2 Global Therapeutic Enzymes Sales in Volume Forecast by Region (2024-2029)
5.3 Global Therapeutic Enzymes Market Size in Value by Region (2018-2029)
5.3.1 Global Therapeutic Enzymes Sales in Value by Region: 2018-2023
5.3.2 Global Therapeutic Enzymes Sales in Value by Region: 2024-2029
6 Americas
6.1 Americas Therapeutic Enzymes Market Size YoY Growth 2018-2029
6.2 Americas Therapeutic Enzymes Sales in Volume, by Type (2018, 2022 & 2029)
6.3 Americas Therapeutic Enzymes Sales in Volume, by Application (2018, 2022 & 2029)
6.4 Americas Therapeutic Enzymes Market Facts & Figures by Country (2018, 2022 & 2029)
6.4.1 Americas Therapeutic Enzymes Sales in Value by Country (2018, 2022 & 2029)
6.4.2 Americas Therapeutic Enzymes Sales in Volume by Country (2018, 2022 & 2029)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Therapeutic Enzymes Market Size YoY Growth 2018-2029
7.2 EMEA Therapeutic Enzymes Sales in Volume, by Type (2018, 2022 & 2029)
7.3 EMEA Therapeutic Enzymes Sales in Volume, by Application (2018, 2022 & 2029)
7.4 EMEA Therapeutic Enzymes Market Facts & Figures by Country (2018, 2022 & 2029)
7.4.1 EMEA Therapeutic Enzymes Sales in Value by Country (2018, 2022 & 2029)
7.4.2 EMEA Therapeutic Enzymes Sales in Volume by Country (2018, 2022 & 2029)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Therapeutic Enzymes Market Size YoY Growth 2018-2029
8.2 China Therapeutic Enzymes Sales in Volume, by Type (2018, 2022 & 2029)
8.3 China Therapeutic Enzymes Sales in Volume, by Application (2018, 2022 & 2029)
9 APAC
9.1 APAC Therapeutic Enzymes Market Size YoY Growth 2018-2029
9.2 APAC Therapeutic Enzymes Sales in Volume, by Type (2018, 2022 & 2029)
9.3 APAC Therapeutic Enzymes Sales in Volume, by Application (2018, 2022 & 2029)
9.4 APAC Therapeutic Enzymes Market Facts & Figures by Region (2018, 2022 & 2029)
9.4.1 APAC Therapeutic Enzymes Sales in Value by Region (2018, 2022 & 2029)
9.4.2 APAC Therapeutic Enzymes Sales in Volume by Region (2018, 2022 & 2029)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Sanofi
10.1.1 Sanofi Company Information
10.1.2 Sanofi Description and Business Overview
10.1.3 Sanofi Therapeutic Enzymes Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Sanofi Therapeutic Enzymes Products Offered
10.1.5 Sanofi Recent Development
10.2 BioMarin
10.2.1 BioMarin Company Information
10.2.2 BioMarin Description and Business Overview
10.2.3 BioMarin Therapeutic Enzymes Sales, Revenue and Gross Margin (2018-2023)
10.2.4 BioMarin Therapeutic Enzymes Products Offered
10.2.5 BioMarin Recent Development
10.3 AbbVie
10.3.1 AbbVie Company Information
10.3.2 AbbVie Description and Business Overview
10.3.3 AbbVie Therapeutic Enzymes Sales, Revenue and Gross Margin (2018-2023)
10.3.4 AbbVie Therapeutic Enzymes Products Offered
10.3.5 AbbVie Recent Development
10.4 Shire
10.4.1 Shire Company Information
10.4.2 Shire Description and Business Overview
10.4.3 Shire Therapeutic Enzymes Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Shire Therapeutic Enzymes Products Offered
10.4.5 Shire Recent Development
10.5 Alexion
10.5.1 Alexion Company Information
10.5.2 Alexion Description and Business Overview
10.5.3 Alexion Therapeutic Enzymes Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Alexion Therapeutic Enzymes Products Offered
10.5.5 Alexion Recent Development
10.6 Horizon Pharma
10.6.1 Horizon Pharma Company Information
10.6.2 Horizon Pharma Description and Business Overview
10.6.3 Horizon Pharma Therapeutic Enzymes Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Horizon Pharma Therapeutic Enzymes Products Offered
10.6.5 Horizon Pharma Recent Development
10.7 Allergan
10.7.1 Allergan Company Information
10.7.2 Allergan Description and Business Overview
10.7.3 Allergan Therapeutic Enzymes Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Allergan Therapeutic Enzymes Products Offered
10.7.5 Allergan Recent Development
10.8 Johnson & Johnson
10.8.1 Johnson & Johnson Company Information
10.8.2 Johnson & Johnson Description and Business Overview
10.8.3 Johnson & Johnson Therapeutic Enzymes Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Johnson & Johnson Therapeutic Enzymes Products Offered
10.8.5 Johnson & Johnson Recent Development
10.9 Recordati Rare Diseases
10.9.1 Recordati Rare Diseases Company Information
10.9.2 Recordati Rare Diseases Description and Business Overview
10.9.3 Recordati Rare Diseases Therapeutic Enzymes Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Recordati Rare Diseases Therapeutic Enzymes Products Offered
10.9.5 Recordati Rare Diseases Recent Development
10.10 Pfizer
10.10.1 Pfizer Company Information
10.10.2 Pfizer Description and Business Overview
10.10.3 Pfizer Therapeutic Enzymes Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Pfizer Therapeutic Enzymes Products Offered
10.10.5 Pfizer Recent Development
10.11 Vivus
10.11.1 Vivus Company Information
10.11.2 Vivus Description and Business Overview
10.11.3 Vivus Therapeutic Enzymes Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Vivus Therapeutic Enzymes Products Offered
10.11.5 Vivus Recent Development
10.12 Digestive Care
10.12.1 Digestive Care Company Information
10.12.2 Digestive Care Description and Business Overview
10.12.3 Digestive Care Therapeutic Enzymes Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Digestive Care Therapeutic Enzymes Products Offered
10.12.5 Digestive Care Recent Development
10.13 Leadiant Biosciences
10.13.1 Leadiant Biosciences Company Information
10.13.2 Leadiant Biosciences Description and Business Overview
10.13.3 Leadiant Biosciences Therapeutic Enzymes Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Leadiant Biosciences Therapeutic Enzymes Products Offered
10.13.5 Leadiant Biosciences Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Therapeutic Enzymes Industry Chain Analysis
11.2 Therapeutic Enzymes Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Therapeutic Enzymes Production Mode & Process
11.4 Therapeutic Enzymes Sales and Marketing
11.4.1 Therapeutic Enzymes Sales Channels
11.4.2 Therapeutic Enzymes Distributors
11.5 Therapeutic Enzymes Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
    Table 1. Therapeutic Enzymes CAGR in Value, India VS Global, 2018 VS 2022 VS 2029
    Table 2. Therapeutic Enzymes Market Trends
    Table 3. Therapeutic Enzymes Market Drivers
    Table 4. Therapeutic Enzymes Market Challenges
    Table 5. Therapeutic Enzymes Market Restraints
    Table 6. Global Therapeutic Enzymes Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 7. India Therapeutic Enzymes Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 8. Global Therapeutic Enzymes Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 9. India Therapeutic Enzymes Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 10. Global Key Manufacturers of Therapeutic Enzymes, Ranked by Revenue (2022) & (US$ Million)
    Table 11. Global Therapeutic Enzymes Revenue by Manufacturer, (US$ Million), 2018-2023
    Table 12. Global Therapeutic Enzymes Revenue Share by Manufacturer, 2018-2023
    Table 13. Global Therapeutic Enzymes Sales by Manufacturer, (K Units), 2018-2023
    Table 14. Global Therapeutic Enzymes Sales Share by Manufacturer, 2018-2023
    Table 15. Global Therapeutic Enzymes Price by Manufacturer (2018-2023) & (USD/Unit)
    Table 16. Global Therapeutic Enzymes Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Therapeutic Enzymes by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Enzymes as of 2022)
    Table 18. Global Key Manufacturers of Therapeutic Enzymes, Manufacturing Base Distribution and Headquarters
    Table 19. Global Key Manufacturers of Therapeutic Enzymes, Product Offered and Application
    Table 20. Global Key Manufacturers of Therapeutic Enzymes, Date of Enter into This Industry
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Key Players of Therapeutic Enzymes in India, Ranked by Revenue (2022) & (US$ million)
    Table 23. India Therapeutic Enzymes Revenue by Players, (US$ Million), (2018-2023)
    Table 24. India Therapeutic Enzymes Revenue Share by Players, (2018-2023)
    Table 25. India Therapeutic Enzymes Sales by Players, (K Units), (2018-2023)
    Table 26. India Therapeutic Enzymes Sales Share by Players, (2018-2023)
    Table 27. Global Therapeutic Enzymes Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 28. Global Therapeutic Enzymes Sales in Volume by Region (2018-2023) & (K Units)
    Table 29. Global Therapeutic Enzymes Sales in Volume Forecast by Region (2024-2029) & (K Units)
    Table 30. Global Therapeutic Enzymes Sales in Value by Region (2018-2023) & (US$ Million)
    Table 31. Global Therapeutic Enzymes Sales in Value Forecast by Region (2024-2029) & (US$ Million)
    Table 32. Americas Therapeutic Enzymes Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 33. Americas Therapeutic Enzymes Sales in Value by Country (2018-2023) & (US$ Million)
    Table 34. Americas Therapeutic Enzymes Sales in Value by Country (2024-2029) & (US$ Million)
    Table 35. Americas Therapeutic Enzymes Sales in Volume by Country (2018-2023) & (K Units)
    Table 36. Americas Therapeutic Enzymes Sales in Volume by Country (2024-2029) & (K Units)
    Table 37. EMEA Therapeutic Enzymes Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 38. EMEA Therapeutic Enzymes Sales in Value by Country (2018-2023) & (US$ Million)
    Table 39. EMEA Therapeutic Enzymes Sales in Value by Country (2024-2029) & (US$ Million)
    Table 40. EMEA Therapeutic Enzymes Sales in Volume by Country (2018-2023) & (K Units)
    Table 41. EMEA Therapeutic Enzymes Sales in Volume by Country (2024-2029) & (K Units)
    Table 42. APAC Therapeutic Enzymes Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 43. APAC Therapeutic Enzymes Sales in Value by Country (2018-2023) & (US$ Million)
    Table 44. APAC Therapeutic Enzymes Sales in Value by Country (2024-2029) & (US$ Million)
    Table 45. APAC Therapeutic Enzymes Sales in Volume by Country (2018-2023) & (K Units)
    Table 46. APAC Therapeutic Enzymes Sales in Volume by Country (2024-2029) & (K Units)
    Table 47. Sanofi Company Information
    Table 48. Sanofi Description and Business Overview
    Table 49. Sanofi Therapeutic Enzymes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 50. Sanofi Therapeutic Enzymes Product
    Table 51. Sanofi Recent Development
    Table 52. BioMarin Company Information
    Table 53. BioMarin Description and Business Overview
    Table 54. BioMarin Therapeutic Enzymes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 55. BioMarin Therapeutic Enzymes Product
    Table 56. BioMarin Recent Development
    Table 57. AbbVie Company Information
    Table 58. AbbVie Description and Business Overview
    Table 59. AbbVie Therapeutic Enzymes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 60. AbbVie Therapeutic Enzymes Product
    Table 61. AbbVie Recent Development
    Table 62. Shire Company Information
    Table 63. Shire Description and Business Overview
    Table 64. Shire Therapeutic Enzymes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 65. Shire Therapeutic Enzymes Product
    Table 66. Shire Recent Development
    Table 67. Alexion Company Information
    Table 68. Alexion Description and Business Overview
    Table 69. Alexion Therapeutic Enzymes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 70. Alexion Therapeutic Enzymes Product
    Table 71. Alexion Recent Development
    Table 72. Horizon Pharma Company Information
    Table 73. Horizon Pharma Description and Business Overview
    Table 74. Horizon Pharma Therapeutic Enzymes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 75. Horizon Pharma Therapeutic Enzymes Product
    Table 76. Horizon Pharma Recent Development
    Table 77. Allergan Company Information
    Table 78. Allergan Description and Business Overview
    Table 79. Allergan Therapeutic Enzymes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 80. Allergan Therapeutic Enzymes Product
    Table 81. Allergan Recent Development
    Table 82. Johnson & Johnson Company Information
    Table 83. Johnson & Johnson Description and Business Overview
    Table 84. Johnson & Johnson Therapeutic Enzymes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 85. Johnson & Johnson Therapeutic Enzymes Product
    Table 86. Johnson & Johnson Recent Development
    Table 87. Recordati Rare Diseases Company Information
    Table 88. Recordati Rare Diseases Description and Business Overview
    Table 89. Recordati Rare Diseases Therapeutic Enzymes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 90. Recordati Rare Diseases Therapeutic Enzymes Product
    Table 91. Recordati Rare Diseases Recent Development
    Table 92. Pfizer Company Information
    Table 93. Pfizer Description and Business Overview
    Table 94. Pfizer Therapeutic Enzymes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 95. Pfizer Therapeutic Enzymes Product
    Table 96. Pfizer Recent Development
    Table 97. Vivus Company Information
    Table 98. Vivus Description and Business Overview
    Table 99. Vivus Therapeutic Enzymes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 100. Vivus Therapeutic Enzymes Product
    Table 101. Vivus Recent Development
    Table 102. Digestive Care Company Information
    Table 103. Digestive Care Description and Business Overview
    Table 104. Digestive Care Therapeutic Enzymes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 105. Digestive Care Therapeutic Enzymes Product
    Table 106. Digestive Care Recent Development
    Table 107. Leadiant Biosciences Company Information
    Table 108. Leadiant Biosciences Description and Business Overview
    Table 109. Leadiant Biosciences Therapeutic Enzymes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 110. Leadiant Biosciences Therapeutic Enzymes Product
    Table 111. Leadiant Biosciences Recent Development
    Table 112. Key Raw Materials Lists
    Table 113. Raw Materials Key Suppliers Lists
    Table 114. Therapeutic Enzymes Customers List
    Table 115. Therapeutic Enzymes Distributors List
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Therapeutic Enzymes Product Picture
    Figure 2. Global Therapeutic Enzymes Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Therapeutic Enzymes Market Size 2018-2029 (US$ Million)
    Figure 4. Global Therapeutic Enzymes Sales 2018-2029 (K Units)
    Figure 5. India Therapeutic Enzymes Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 6. India Therapeutic Enzymes Market Size 2018-2029 (US$ Million)
    Figure 7. India Therapeutic Enzymes Sales 2018-2029 (K Units)
    Figure 8. India Therapeutic Enzymes Market Share in Global, in Value (US$ Million) 2018-2029
    Figure 9. India Therapeutic Enzymes Market Share in Global, in Volume (K Units) 2018-2029
    Figure 10. Therapeutic Enzymes Report Years Considered
    Figure 11. Product Picture of Injectable
    Figure 12. Product Picture of Oral
    Figure 13. Product Picture of Topical
    Figure 14. Global Therapeutic Enzymes Market Share by Type in 2022 & 2029
    Figure 15. Global Therapeutic Enzymes Sales in Value by Type (2018-2029) & (US$ Million)
    Figure 16. Global Therapeutic Enzymes Sales Market Share in Value by Type (2018-2029)
    Figure 17. Global Therapeutic Enzymes Sales by Type (2018-2029) & (K Units)
    Figure 18. Global Therapeutic Enzymes Sales Market Share in Volume by Type (2018-2029)
    Figure 19. Global Therapeutic Enzymes Price by Type (2018-2029) & (USD/Unit)
    Figure 20. India Therapeutic Enzymes Market Share by Type in 2022 & 2029
    Figure 21. India Therapeutic Enzymes Sales in Value by Type (2018-2029) & (US$ Million)
    Figure 22. India Therapeutic Enzymes Sales Market Share in Value by Type (2018-2029)
    Figure 23. India Therapeutic Enzymes Sales by Type (2018-2029) & (K Units)
    Figure 24. India Therapeutic Enzymes Sales Market Share in Volume by Type (2018-2029)
    Figure 25. India Therapeutic Enzymes Price by Type (2018-2029) & (USD/Unit)
    Figure 26. Product Picture of Gaucher Disease
    Figure 27. Product Picture of MPS Disease
    Figure 28. Product Picture of Gastrointestinal Diseases
    Figure 29. Product Picture of Others
    Figure 30. Global Therapeutic Enzymes Market Share by Application in 2022 & 2029
    Figure 31. Global Therapeutic Enzymes Sales in Value by Application (2018-2029) & (US$ Million)
    Figure 32. Global Therapeutic Enzymes Sales Market Share in Value by Application (2018-2029)
    Figure 33. Global Therapeutic Enzymes Sales by Application (2018-2029) & (K Units)
    Figure 34. Global Therapeutic Enzymes Sales Market Share in Volume by Application (2018-2029)
    Figure 35. Global Therapeutic Enzymes Price by Application (2018-2029) & (USD/Unit)
    Figure 36. India Therapeutic Enzymes Market Share by Application in 2022 & 2029
    Figure 37. India Therapeutic Enzymes Sales in Value by Application (2018-2029) & (US$ Million)
    Figure 38. India Therapeutic Enzymes Sales Market Share in Value by Application (2018-2029)
    Figure 39. India Therapeutic Enzymes Sales by Application (2018-2029) & (K Units)
    Figure 40. India Therapeutic Enzymes Sales Market Share in Volume by Application (2018-2029)
    Figure 41. India Therapeutic Enzymes Price by Application (2018-2029) & (USD/Unit)
    Figure 42. Americas Therapeutic Enzymes Sales in Volume Growth Rate 2018-2029 (K Units)
    Figure 43. Americas Therapeutic Enzymes Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 44. Americas Therapeutic Enzymes Sales by Type (2018-2029) & (K Units)
    Figure 45. Americas Therapeutic Enzymes Sales Market Share in Volume by Type (2018-2029)
    Figure 46. Americas Therapeutic Enzymes Sales by Application (2018-2029) & (K Units)
    Figure 47. Americas Therapeutic Enzymes Sales Market Share in Volume by Application (2018-2029)
    Figure 48. United States Therapeutic Enzymes Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 49. Canada Therapeutic Enzymes Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 50. Mexico Therapeutic Enzymes Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 51. Brazil Therapeutic Enzymes Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 52. EMEA Therapeutic Enzymes Sales in Volume Growth Rate 2018-2029 (K Units)
    Figure 53. EMEA Therapeutic Enzymes Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 54. EMEA Therapeutic Enzymes Sales by Type (2018-2029) & (K Units)
    Figure 55. EMEA Therapeutic Enzymes Sales Market Share in Volume by Type (2018-2029)
    Figure 56. EMEA Therapeutic Enzymes Sales by Application (2018-2029) & (K Units)
    Figure 57. EMEA Therapeutic Enzymes Sales Market Share in Volume by Application (2018-2029)
    Figure 58. Europe Therapeutic Enzymes Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 59. Middle East Therapeutic Enzymes Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 60. Africa Therapeutic Enzymes Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 61. China Therapeutic Enzymes Sales in Volume Growth Rate 2018-2029 (K Units)
    Figure 62. China Therapeutic Enzymes Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 63. China Therapeutic Enzymes Sales by Type (2018-2029) & (K Units)
    Figure 64. China Therapeutic Enzymes Sales Market Share in Volume by Type (2018-2029)
    Figure 65. China Therapeutic Enzymes Sales by Application (2018-2029) & (K Units)
    Figure 66. China Therapeutic Enzymes Sales Market Share in Volume by Application (2018-2029)
    Figure 67. APAC Therapeutic Enzymes Sales in Volume Growth Rate 2018-2029 (K Units)
    Figure 68. APAC Therapeutic Enzymes Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 69. APAC Therapeutic Enzymes Sales by Type (2018-2029) & (K Units)
    Figure 70. APAC Therapeutic Enzymes Sales Market Share in Volume by Type (2018-2029)
    Figure 71. APAC Therapeutic Enzymes Sales by Application (2018-2029) & (K Units)
    Figure 72. APAC Therapeutic Enzymes Sales Market Share in Volume by Application (2018-2029)
    Figure 73. Japan Therapeutic Enzymes Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 74. South Korea Therapeutic Enzymes Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 75. China Taiwan Therapeutic Enzymes Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 76. Southeast Asia Therapeutic Enzymes Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 77. India Therapeutic Enzymes Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 78. Therapeutic Enzymes Value Chain
    Figure 79. Therapeutic Enzymes Production Process
    Figure 80. Channels of Distribution
    Figure 81. Distributors Profiles
    Figure 82. Bottom-up and Top-down Approaches for This Report
    Figure 83. Data Triangulation
    Figure 84. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4350

This license allows only one user to access the PDF.
Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS